可问题是，现有的治疗装置如同一个庞然大物，占地面积巨大，建造成本高昂，治疗费用不菲，救 治患者的数量也有限。我们希望通过技术革新，让这台承载"希望之光"的医疗利器，占地面积更小，运 行更高效，从而惠及更多患者。所以，建设普惠型重离子加速器治疗装置的迫切性越来越高。 为此，我们开展集中技术攻关。首先，我们瞄准设备的"心脏"——同步加速器。国际上该装置最短 周长为56米，我们采用紧凑型光学设计和原创变场梯度引出方案，将周长压缩到35米，占地面积缩减到 原来的1/3，这样一来，设备能适用于更多医院。 "小"还不是最终目标。我们希望治疗装置不仅能"瘦身"，还能"变强"。团队研发的医用无液氦超导 强流离子源，让束流强度达到1毫安，是国际最高水平的3倍多，这样一来，治疗"弹药"就更充足了。团 队还研发出"高性能束流智能配送系统"，让一条旋转束线能同时对接8个治疗室，从而提升治疗效率， 缩短患者等待时间。 强化科技基础条件自主保障，统筹科技创新平台基地建设。 ——摘自"十五五"规划建议 前不久，强流重离子加速器实现束流全线贯通，这台位于广东惠州的国家重大科技基础设施，不仅 能提供国际脉冲流强最高的重离子束流，还搭载了精度很 ...

合肥新奈医疗科技有限公司是一家专注于智能呼吸治疗设备研发的新锐医疗科技公司，新奈Synaire聚 焦瑞思迈等品牌垄断的中高端细分市场，通过"高端性能 + 中端价格"的策略迅速切入，以To B（医院、 药房、保险）启动，To C逐步渗透家庭消费市场，构建"先专业后消费"的品牌演进路径。 数据来源：天眼查APP 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，根据天眼查APP于12月11日公布的信息整理，合肥新奈医疗科技有限公司Pre-A轮融 资，融资额数千万人民币，参与投资的机构包括水木创投，华盖资本，包河创投。 ...

Core Insights - A new non-contact atrial fibrillation (AF) detection system has been developed by a team of Chinese scientists, utilizing radar sensing and artificial intelligence (AI) technology to monitor arrhythmia symptoms wirelessly, potentially allowing for earlier detection and intervention compared to traditional clinical methods [1][3]. Group 1: Technology and Methodology - The system captures sub-millimeter heart movements remotely using radio signals and employs a knowledge transfer-driven AI framework to identify AF patterns from electrocardiogram (ECG) diagnostics [3]. - The innovative approach establishes a mapping between cardiac electrical activity and mechanical motion, leveraging validated ECG signal features to assist neural networks in recognizing abnormal mechanical fluctuations specific to AF [3]. Group 2: Clinical Evaluation - The research team evaluated the non-contact AF detection system using data from 6,258 outpatient patients, including 229 AF patients, and found that the system's sensitivity and specificity in detecting AF were comparable to that of ECG [3]. - Further testing on 27 patients during regular sleep demonstrated the system's potential in detecting the presence and episodes of AF [3][4]. Group 3: Future Implications - The non-contact AF detection system shows promise for deployment in everyday life, which could facilitate large-scale early screening and proactive management of AF patients [4].

Group 1 - The core concept of equity income rights financing agreements involves separating ownership and income rights to meet specific financing needs, which can be exploited for illicit benefits in cases of bribery [1] - In a case involving a state-owned company, an executive misused their position to facilitate a private company's financing through an equity income rights agreement, leading to significant financial losses for the state-owned entity [2][3] - The financing agreement was structured to avoid regulatory scrutiny by transferring only income rights, allowing the actual investors to remain anonymous [1][2] Group 2 - The private company, B, sought investment from the state-owned A company for a high-end medical device project, but faced challenges due to high initial costs and long profit cycles [2] - The executive, referred to as A, facilitated the investment by manipulating project evaluations and bypassing standard risk controls, resulting in a 600 million yuan investment from A company into B's project [2][3] - Following B's successful IPO, the executive arranged for a low-priced transfer of income rights, which significantly undervalued the asset compared to market rates, indicating a potential scheme for profit extraction [3][8] Group 3 - The case raised legal debates regarding whether the executive's actions constituted bribery or merely market transactions, with differing opinions on how to assess the value of the received benefits [4][5] - The analysis concluded that the executive's actions were indeed a form of bribery, as they involved a clear agreement to exchange benefits for favorable treatment in investment decisions [6][11] - The executive's actions led to a significant loss for the state-owned company, amounting to 180 million yuan due to the misrepresentation of the private company's financial health [3][12]